Sign in

You're signed outSign in or to get full access.

Amy B. R. Lancellotta

About Amy B. R. Lancellotta

Amy B. R. Lancellotta (born 1959) is an Independent Board Member of Nuveen Virginia Quality Municipal Income Fund (NPV) and other Nuveen funds, serving since 2021; she is a lawyer by training (J.D., George Washington University Law School, 1984; B.A., Pennsylvania State University, 1981) with three decades of fund governance leadership at the Investment Company Institute (ICI) and its Independent Directors Council (IDC) . She oversees 218 portfolios in the Nuveen fund complex, is classified as a Class II Board Member with a term through the 2026 annual meeting, and is explicitly designated “Independent” under the 1940 Act and exchange standards (never an employee or director of TIAA or Nuveen or affiliates) .

Past Roles

OrganizationRoleTenureCommittees/Impact
Independent Directors Council (IDC, part of ICI)Managing Director2006–2019Led education, governance and policy initiatives for fund independent directors; advised on fund governance issues
Investment Company Institute (ICI)Various positions1989–2006Advanced industry initiatives affecting funds and shareholders
Washington, D.C. law firmsAssociatePre-1989Legal background prior to ICI career

External Roles

OrganizationRoleTenureNotes
Jewish Coalition Against Domestic Abuse (JCADA)President; DirectorPresident since 2023; Director since 2020Non-profit board leadership; no public company board disclosed

Board Governance

  • Independence: All nominees and current Board Members (including Lancellotta) are not “interested persons” under the 1940 Act and have never been employees or directors of TIAA or Nuveen, thus deemed “Independent Board Members” .
  • Committee assignments: Audit Committee member ; Dividend Committee member ; Nominating and Governance Committee member ; Investment Committee Co‑Chair .
  • Responsibilities context: Audit Committee oversees financial reporting, auditor independence, valuation policy and financial risk disclosures ; Investment Committee oversees fund performance, risk, leverage/hedging, and portfolio-related matters .
  • Attendance: Each Board Member attended at least 75% of applicable Board and committee meetings during the last fiscal year .
  • Term and service: Joined the Board in 2021; Class II term runs to 2026 for NPV .

Meetings held (last fiscal year) – Virginia Municipal (NPV):

Meeting TypeCount
Regular Board5
Special Board8
Executive Committee8
Dividend Committee10
Compliance, Risk Management & Regulatory Oversight Committee6
Audit Committee15
Nominating & Governance Committee5
Investment Committee4
Closed‑End Fund Committee4

Fixed Compensation

Compensation structure (effective January 1, 2024; increases noted effective January 1, 2025):

ComponentAmountNotes
Annual Board Retainer$350,000Independent Board Members
Committee Membership Retainer – Audit$30,000 → $35,000 (2025)Per member, annual
Committee Membership Retainer – Compliance, Risk Mgmt & Regulatory Oversight$30,000 → $35,000 (2025)Per member, annual
Committee Membership Retainer – Investment$20,000 → $30,000 (2025)Per member, annual
Committee Membership Retainer – Dividend$20,000 → $25,000 (2025)Per member, annual
Committee Membership Retainer – Nominating & Governance$20,000 → $25,000 (2025)Per member, annual
Committee Membership Retainer – Closed‑End Funds$20,000 → $25,000 (2025)Per member, annual
Chair/Co‑Chair – Board$140,000 → $150,000 (2025)Annual
Chair/Co‑Chair – Audit & Compliance$30,000 → $35,000 (2025)Annual
Chair/Co‑Chair – Investment$20,000 → $30,000 (2025)Annual
Chair/Co‑Chair – Dividend, Nominating & Governance, Closed‑End Funds$20,000 → $25,000 (2025)Annual
Ad hoc Board/Committee meetings$1,000 or $2,500Depending on length/immediacy
Special assignment committeesChair/co‑chair quarterly fee from $1,250; members quarterly fee from $5,000

2023 legacy structure (pre‑2024):

ComponentAmountNotes
Annual Board Retainer$210,0002023 amount
Regular Board meetings$7,250 per dayPer day attendance
Special Board meetings$4,000 per meeting
Audit, Closed‑End, Investment Committee meetings$2,500 per meeting
Compliance, Risk Mgmt & Regulatory Oversight Committee meetings$5,000 per meeting
Dividend Committee meetings$1,250 per meeting
All other committee meetings$500 per meeting
Executive Committee acting as IPO pricing committee$100 per meeting
Site visits (service providers)$5,000 per day
Board Chair retainer$140,000
Committee chair retainers$20,000Audit, Dividend, Compliance, N&G, Closed‑End, Investment

Actual compensation paid (last fiscal year):

ScopeAmount to Lancellotta
NPV (Virginia Municipal) – Aggregate from Fund$1,126
Total compensation from funds in the Fund Complex$469,250

Deferred compensation elections:

  • Independent Board Members may elect to defer compensation into a notional account tracking eligible Nuveen funds; distributions can be lump sum or over 2–20 years; Fund has no liability for other funds’ obligations under the plan .
  • Deferred fees (illustrative amounts): For NPV, Lancellotta has $395 in deferred fees/payable under the plan; similar amounts are shown for other funds (see Appendix table) .

Performance Compensation

  • No performance‑based incentives (no bonus, stock awards, option awards, or stated performance metrics) are disclosed for Independent Board Members; compensation is retainers/fees with an optional deferred compensation plan .
  • The Funds do not have retirement or pension plans for Board Members .

Other Directorships & Interlocks

Company/OrganizationTypeRoleCommitteesDatesInterlock/Conflict Note
JCADANon‑profitPresident; DirectorPresident since 2023; Director since 2020Non‑profit; no public company directorship disclosed

Expertise & Qualifications

  • Fund governance expertise: Led IDC and advised ICI, independent directors and the fund industry on governance and fiduciary responsibilities; directed education and policy initiatives .
  • Legal training: J.D. (1984) and prior associate roles at Washington, D.C. law firms .
  • Industry experience: 30 years at ICI/IDC; deep knowledge of regulated investment companies and board governance .
  • Oversight scale: Oversees 218 portfolios in the Nuveen fund complex .

Equity Ownership

ItemLancellotta Position
NPV dollar range of equity securities beneficially owned$0
NPV shares owned (including share equivalents via deferred comp plan)0
NPV shares outstanding (Common; Preferred)18,245,696 Common; 1,280 VRDP
Ownership % of NPV Common0.00% (derived from 0/18,245,696)
Aggregate range of equity securities in all registered investment companies overseen (family of investment companies)Over $100,000

As of Feb 18, 2025, each Board Member’s individual beneficial shareholdings of each Fund were less than 1% of outstanding shares; Board Members and officers as a group also owned less than 1% for each Fund .

Governance Assessment

  • Strengths: Independence clearly established; extensive fund governance expertise; active engagement across key oversight committees (Audit, Nominating & Governance, Dividend) and serves as Co‑Chair of the Investment Committee—directly aligned with performance and risk oversight .
  • Engagement: Board and committees met frequently; each Board Member attended ≥75% of applicable meetings—supports effective oversight cadence for NPV (Audit met 15 times; Dividend 10; etc.) .
  • Compensation structure: Shift from 2023 per‑meeting fees to 2024+ fixed annual retainers for committee membership/chairs enhances predictability but maintains at‑risk (time/role‑based) elements via ad hoc/special assignment fees; Lancellotta’s actual aggregate compensation from NPV was $1,126 and $469,250 across the complex .
  • Alignment considerations (RED FLAG for some investors): No direct ownership in NPV (zero shares; $0 dollar range), though she reports “Over $100,000” aggregate holdings across the family of registered investment companies; participation in the deferred compensation plan links her compensation to fund performance but is not direct share ownership of NPV .
  • Conflicts/related‑party: No related‑party transactions or holdings disclosed for Lancellotta in the adviser‑affiliated private vehicles list; Section 16(a) compliance indicated for Board Members/officers .
Citations:
**[897421_0001193125-25-045746_d930587ddef14a.htm:7]** **[897421_0001193125-25-045746_d930587ddef14a.htm:9]** **[897421_0001193125-25-045746_d930587ddef14a.htm:12]** **[897421_0001193125-25-045746_d930587ddef14a.htm:13]** **[897421_0001193125-25-045746_d930587ddef14a.htm:14]** **[897421_0001193125-25-045746_d930587ddef14a.htm:15]** **[897421_0001193125-25-045746_d930587ddef14a.htm:20]** **[897421_0001193125-25-045746_d930587ddef14a.htm:21]** **[897421_0001193125-25-045746_d930587ddef14a.htm:22]** **[897421_0001193125-25-045746_d930587ddef14a.htm:23]** **[897421_0001193125-25-045746_d930587ddef14a.htm:25]** **[897421_0001193125-25-045746_d930587ddef14a.htm:26]** **[897421_0001193125-25-045746_d930587ddef14a.htm:29]** **[897421_0001193125-25-045746_d930587ddef14a.htm:30]** **[897421_0001193125-25-045746_d930587ddef14a.htm:32]** **[897421_0001193125-25-045746_d930587ddef14a.htm:41]** **[897421_0001193125-25-045746_d930587ddef14a.htm:44]** **[897421_0001193125-25-045746_d930587ddef14a.htm:48]** **[897421_0001193125-25-045746_d930587ddef14a.htm:49]** **[897421_0001193125-25-045746_d930587ddef14a.htm:52]**